Patents by Inventor Steven Korte

Steven Korte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9868937
    Abstract: Compositions and methods for improving cardiac function, myocardial contractility and relaxation in a mammal are provided. Cardiomyocytes transfected with one or more expression vectors comprising a ribonucleotide reductase subunit R1-encoding nucleic acid sequence and a ribonucleotide reductase subunit R2-encoding nucleic acid sequence operably linked to a promoter are grafted to a mammalian myocardium. Also provided are compositions and methods for delivering dATP to a myocardium through grafting of donor cells overexpressing R1 and R2. dATP is thereby produced in situ and delivered through gap junctions established between donor cells and host cardiomyocytes. Alternatively, viral vector(s) having the R1 and R2-encoding construct(s) are administered to the mammal directly. Improvement of cardiac function can also be effected by administration of vectors comprising a nucleic acid sequence encoding a L48Q, 61 Q, or L57Q cTnC variant.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: January 16, 2018
    Assignee: University of Washington
    Inventors: Michael Regnier, Michael Laflamme, Charles Murry, F. Steven Korte, Scott Lundy, Stephen Denison Hauschka, Jeffrey S. Chamberlain, Guy Odom
  • Publication number: 20160186139
    Abstract: Compositions and methods for improving cardiac function, myocardial contractility and relaxation in a mammal are provided. Cardiomyocytes transfected with one or more expression vectors comprising a ribonucleotide reductase subunit R1-encoding nucleic acid sequence and a ribonucleotide reductase subunit R2-encoding nucleic acid sequence operably linked to a promoter are grafted to a mammalian myocardium. Also provided are compositions and methods for delivering dATP to a myocardium through grafting of donor cells overexpressing R1 and R2. dATP is thereby produced in situ and delivered through gap junctions established between donor cells and host cardiomyocytes. Alternatively, viral vector(s) having the R1 and R2-encoding construct(s) are administered to the mammal directly. Improvement of cardiac function can also be effected by administration of vectors comprising a nucleic acid sequence encoding a L48Q, 61 Q, or L57Q cTnC variant.
    Type: Application
    Filed: May 29, 2012
    Publication date: June 30, 2016
    Applicant: University of Washington
    Inventors: Michael Regnier, Michael Laflamme, Charles Murry, F. Steven Korte, Scott Lundy, Stephen Denison Hauschka, Jeffrey S. Chamberlain
  • Patent number: 7314161
    Abstract: A privacy apparatus (42) is installed on an existing ATM (12) to provide improved privacy for users of the machine. A frame (44) includes members (48, 56, 64) and extends externally of the ATM housing (14). A pair of disposed vertically extending panels (46) are attached in supporting connection with the frame. Each panel includes a generally horizontally extending shelf (76) which provides a support and writing surface. The privacy apparatus may be readily installed and removed without a requirement for producing fastener openings or other modifications to the existing ATM housing.
    Type: Grant
    Filed: October 17, 2003
    Date of Patent: January 1, 2008
    Assignee: Diebold SCLF - Service Systems division of Diebold, Incorporated
    Inventors: Steven Korte, Donald S. Nelson, Jr., Michael J. Maczuzak, Jesse P. Carlson
  • Patent number: D492085
    Type: Grant
    Filed: October 17, 2003
    Date of Patent: June 22, 2004
    Assignee: Diebold Self-Service Systems a division of Diebold, Incorporated
    Inventors: Steven Korte, Donald S. Nelson, Jr., Michael J. Maczuzak, Jesse P. Carlson